On March 11, 2019 Sirnaomics Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, reported that the Company’s management will present its platform technology and discuss the potential utility of RNAi therapeutics at the 4th Annual Oligonucleotide & Precision Therapeutics: Discovery, Development and Delivery conference on March 25-28, 2019 in Cambridge, Massachusetts (Press release, Sirnaomics, MAR 11, 2019, View Source;precision-therapeutics-discovery-development-and-delivery-300810415.html [SID1234534208]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Patrick Lu, PhD, President and Chief Executive Officer, will share an overview of Sirnaomics’ differentiated RNAi technology platform, which leverages a proprietary polypeptide nanoparticle (PNP) drug delivery system, and the Company’s pipeline of RNAi therapeutics spanning oncology and anti-fibrosis indications at the following presentations.
Presentation: Chairperson’s RemarksDate & Time: March 26, 10:45 am ET
Presentation Title: Novel siRNA Therapeutics for Immune Oncology TherapeuticsPresentation Track: Oligonucleotide Discovery and DeliveryDate & Time: March 26, 2 pm ET
Presentation Title: Can We Push for siRNA Cancer Therapeutics Similar to Experiences with mAbs?Date & Time: March 27, 8 am ET
Also, Dmitry Samarsky, PhD, Chief Technology Officer of Sirnaomics, will chair a short course, "Examining The Safety and Toxicity of Nucleic Acid Therapeutics", on Monday, March 25 starting at 6:50 pm ET. He will also participate in a panel discussion, "Bridging the Gap between Discovery, Development and Compliance", on Tuesday, March 26 at 9:15 am ET.